These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 1834712

  • 21. Topically applied antibiotics in acne vulgaris: clinical response and suppression of Corynebacterium acnes in open comedones.
    Resh W, Stoughton RB.
    Arch Dermatol; 1976 Feb; 112(2):182-4. PubMed ID: 134675
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. In Vitro activity of 6 antimicrobials against propionibacteria isolates from untreated acne papulopustulosa.
    Fluhr JW, Gloor M, Dietz P, Höffler U.
    Zentralbl Bakteriol; 1999 Feb; 289(1):53-61. PubMed ID: 10096167
    [Abstract] [Full Text] [Related]

  • 24. Sensitivity of Propionibacterium acnes isolated from acne patients: comparative study of antimicrobial agents.
    Nishijima S, Kurokawa I, Kawabata S.
    J Int Med Res; 1996 Feb; 24(6):473-7. PubMed ID: 8959531
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. A Myrtus communis extract enriched in myrtucummulones and ursolic acid reduces resistance of Propionibacterium acnes biofilms to antibiotics used in acne vulgaris.
    Feuillolay C, Pecastaings S, Le Gac C, Fiorini-Puybaret C, Luc J, Joulia P, Roques C.
    Phytomedicine; 2016 Mar 15; 23(3):307-15. PubMed ID: 26969384
    [Abstract] [Full Text] [Related]

  • 31. Effects of Roxithromycin on the production of lipase and neutrophil chemotactic factor by Propionibacterium acnes.
    Akamatsu H, Tomita T, Horio T.
    Dermatology; 2002 Mar 15; 204(4):277-80. PubMed ID: 12077521
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Transconjugation of erm(X) conferring high-level resistance of clindamycin for Cutibacterium acnes.
    Aoki S, Nakase K, Hayashi N, Noguchi N.
    J Med Microbiol; 2019 Jan 15; 68(1):26-30. PubMed ID: 30431414
    [Abstract] [Full Text] [Related]

  • 35. Effect of zinc gluconate on propionibacterium acnes resistance to erythromycin in patients with inflammatory acne: in vitro and in vivo study.
    Dreno B, Foulc P, Reynaud A, Moyse D, Habert H, Richet H.
    Eur J Dermatol; 2005 Jan 15; 15(3):152-5. PubMed ID: 15908296
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. A Multifactorial Comparison of Ternary Combinations of Essential Oils in Topical Preparations to Current Antibiotic Prescription Therapies for the Control of Acne Vulgaris-Associated Bacteria.
    Owen L, Grootveld M, Arroo R, Ruiz-Rodado V, Price P, Laird K.
    Phytother Res; 2017 Mar 15; 31(3):410-417. PubMed ID: 28124400
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Microbiological Profile of Sarecycline, a Novel Targeted Spectrum Tetracycline for the Treatment of Acne Vulgaris.
    Zhanel G, Critchley I, Lin LY, Alvandi N.
    Antimicrob Agents Chemother; 2019 Jan 15; 63(1):. PubMed ID: 30397052
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.